Sign inJoin waitlistJoin the waitlist

Emily Ruiz

Director, High-Risk Skin Cancer Clinic, Dana-Farber Brigham Cancer Center · Mass General Brigham

Credentials: · · · · ·

History

Mass General Brigham
Present
Washington University/B-JH/SLCH Consortium
Present

Brigham and Women's Hospital
2015–2016
Dermatology
Albert Einstein College of Medicine of Yeshiva University
2011–2014
Internal Medicine
NYU Langone Hospitals
2008–2011
New York University Grossman School of Medicine
2006–2010

Research

The abscopal effect associated with a systemic anti-melanoma immune response
Case report · International journal of radiation oncology · 2013 · First of 5 authors · 323 citations
Neoadjuvant Cemiplimab for Stage II to IV Cutaneous Squamous-Cell Carcinoma
New England Journal of Medicine · 2022 · 277 citations
Performance of the American Joint Committee on Cancer Staging Manual, 8th Edition vs the Brigham and Women's Hospital Tumor Classification System for Cutaneous Squamous Cell…
JAMA Dermatology · 2019 · First of 4 authors · 170 citations

CS
Chrysalyne Schmults
57 papers
Shlomo Koyfman
40 papers
Allison Vidimos
37 papers
NR
Nina Ran
35 papers · 34 as a fellow
EG
Emily Granger
32 papers
Ann Silk
30 papers
David Carr
26 papers
JC
John Carucci
26 papers
Ashley Wysong
25 papers
Kathryn Shahwan
25 papers
TW
Tyler Willenbrink
25 papers · 3 as a resident
Aaron Mangold
22 papers

Clinical trials

Daylight Photodynamic Therapy for the Treatment of Actinic Keratoses in the Northeast United States
Principal investigator · Withdrawn
Brigham and Women's Hospital
2020–2022
L19IL2/L19TNF in Patients With Cutaneous Squamous Cell Carcinoma
Site PI · Recruiting · Phase 2
Philogen S.p.A.
2026–2031